TCL, K., ME, F., EC, O., LD, H., EI, T., D, G., . . . NG, V. (2023). Pharmacological targeting of coagulation factor XI attenuates experimental autoimmune encephalomyelitis in mice. Metabolic brain disease, 38(7), 2383. https://doi.org/10.1007/s11011-023-01251-1
Chicago Style (17th ed.) CitationTCL, Kohs, et al. "Pharmacological Targeting of Coagulation Factor XI Attenuates Experimental Autoimmune Encephalomyelitis in Mice." Metabolic Brain Disease 38, no. 7 (2023): 2383. https://doi.org/10.1007/s11011-023-01251-1.
MLA (9th ed.) CitationTCL, Kohs, et al. "Pharmacological Targeting of Coagulation Factor XI Attenuates Experimental Autoimmune Encephalomyelitis in Mice." Metabolic Brain Disease, vol. 38, no. 7, 2023, p. 2383, https://doi.org/10.1007/s11011-023-01251-1.